Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Common Equity (2021 - 2023)

Historic Common Equity for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $424.3 million.

  • Zymeworks' Common Equity rose 13606.4% to $424.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $424.3 million, marking a year-over-year increase of 13606.4%. This contributed to the annual value of $493.0 million for FY2022, which is 9789.96% up from last year.
  • According to the latest figures from Q3 2023, Zymeworks' Common Equity is $424.3 million, which was up 13606.4% from $448.9 million recorded in Q2 2023.
  • Zymeworks' Common Equity's 5-year high stood at $493.0 million during Q4 2022, with a 5-year trough of $179.8 million in Q3 2022.
  • Moreover, its 3-year median value for Common Equity was $436.6 million (2023), whereas its average is $378.1 million.
  • Per our database at Business Quant, Zymeworks' Common Equity soared by 9789.96% in 2022 and then surged by 13606.4% in 2023.
  • Quarter analysis of 3 years shows Zymeworks' Common Equity stood at $249.1 million in 2021, then skyrocketed by 97.9% to $493.0 million in 2022, then decreased by 13.92% to $424.3 million in 2023.
  • Its last three reported values are $424.3 million in Q3 2023, $448.9 million for Q2 2023, and $473.5 million during Q1 2023.